LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹111 Cr | ₹109 Cr | ₹106 Cr | ₹107 Cr | ₹133 Cr |
What is the latest Total Non-Current Assets ratio of LYKA LABS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹111 Cr |
| Mar2025 | ₹109 Cr |
| Mar2024 | ₹106 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹133 Cr |
How is Total Non-Current Assets of LYKA LABS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹111 Cr | 2.29 | |
| Mar2025 | ₹109 Cr | 2.42 | |
| Mar2024 | ₹106 Cr | -1.04 | |
| Mar2023 | ₹107 Cr | -19.56 | |
| Mar2022 | ₹133 Cr | - | |
Compare Total Non-Current Assets of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹249.7 Cr | 6.9% | -5.8% | -39.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 6.9% |
-5.8% |
-39.4% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses